1980 related articles for article (PubMed ID: 16949099)
1. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M
Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516
[TBL] [Abstract][Full Text] [Related]
3. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
4. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
5. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
6. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
[TBL] [Abstract][Full Text] [Related]
7. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
8. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
9. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
Galińska B; Szulc A; Tarasów E; Kubas B; Dzienis W; Siergiejczyk L; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():11-6. PubMed ID: 17507879
[TBL] [Abstract][Full Text] [Related]
10. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
Fujimoto T; Nakano T; Takano T; Takeuchi K; Yamada K; Fukuzako T; Akimoto H
Biol Psychiatry; 1996 Jul; 40(1):14-8. PubMed ID: 8780850
[TBL] [Abstract][Full Text] [Related]
13. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.
Valenzuela MJ; Sachdev PS; Wen W; Shnier R; Brodaty H; Gillies D
Neuroimage; 2000 Dec; 12(6):747-56. PubMed ID: 11112406
[TBL] [Abstract][Full Text] [Related]
14. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
15. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
16. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
Başoğlu C; Cetin M; Oner O; Ebrinç S; Semiz UB; Kandilcioğlu H; Silit E; Kizilkaya E
Turk Psikiyatri Derg; 2006; 17(2):85-91. PubMed ID: 16755408
[TBL] [Abstract][Full Text] [Related]
20. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
Castro-Fornieles J; Bargalló N; Lázaro L; Andrés S; Falcon C; Plana MT; Junqué C
J Psychiatr Res; 2007 Dec; 41(11):952-8. PubMed ID: 17112540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
